Nathaniel Calloway - 28 Oct 2022 Form 3 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ James R. Merchant, Attorney-in-Fact
Issuer symbol
ANEB
Transactions as of
28 Oct 2022
Net transactions value
$0
Form type
3
Filing time
02 Nov 2022, 16:26:54 UTC
Next filing
02 Nov 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.